» Articles » PMID: 20081233

Polymer-based Non-viral Gene Delivery As a Concept for the Treatment of Cancer

Overview
Journal Pharmacol Rep
Specialty Pharmacology
Date 2010 Jan 19
PMID 20081233
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Gene therapy has become a promising technique for the treatment of cancer. Nevertheless, the success of gene therapy depends on the effectiveness of the vector. The challenge of a gene carrier is to deliver exogenous DNA from the site of administration into the nucleus of the appropriate target cell. Polymer-based vectors are biologically safe, have low production costs and are efficient tools for gene therapy. Although non-degradable polyplexes exhibit high gene expression levels, their application potential is limited due to their inability to be effectively eliminated, which results in cytotoxicity. The development of biodegradable polymers has allowed for high levels of transfection without cytotoxicity. For site-specific targeting of polyplexes, further modifications, such as incorporation of ligands, can be performed. Most expectations have been addressed to polyplexes architecture according it dynamic response with the microenvironment.

Citing Articles

Phytochemical Profile and Anticancer Potential of Extracts on Glioblastoma, Bladder Cancer, and Breast Cancer Cells.

Nalkiran I, Sevim Nalkiran H Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40005959 PMC: 11859872. DOI: 10.3390/ph18020144.


Evaluation of a Synthetic Polyethyleneimine Based Polymeric Vector for Gene Delivery to MCF-7 Breast Cancer Cells.

Karagoz U, Kc R, Isel E, Kantarci A, Uludag H Turk J Pharm Sci. 2024; 21(5):449-455.

PMID: 39569682 PMC: 11600320. DOI: 10.4274/tjps.galenos.2023.72430.


Step-by-Step Immune Activation for Suicide Gene Therapy Reinforcement.

Alekseenko I, Kuzmich A, Kondratyeva L, Kondratieva S, Pleshkan V, Sverdlov E Int J Mol Sci. 2021; 22(17).

PMID: 34502287 PMC: 8430744. DOI: 10.3390/ijms22179376.


Bluetongue Virus Particles as Nanoreactors for Enzyme Delivery and Cancer Therapy.

Thuenemann E, Le D, Lomonossoff G, Steinmetz N Mol Pharm. 2021; 18(3):1150-1156.

PMID: 33566625 PMC: 8086382. DOI: 10.1021/acs.molpharmaceut.0c01053.


Novel Histone-Based DNA Carrier Targeting Cancer-Associated Fibroblasts.

Kuzmich A, Rakitina O, Didych D, Potapov V, Zinovyeva M, Alekseenko I Polymers (Basel). 2020; 12(8).

PMID: 32751200 PMC: 7464289. DOI: 10.3390/polym12081695.